Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowMIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
Just nowParatus Energy: Invitation to Q1 2026 Earnings Call
1m ago374Water Provides Conference Update and Reaffirms Tailwinds
1m agoNew Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System
2m agoEdible Garden Starts Shipping New Fresh-Cut Herb Program with Target
Mannkind Corporation logo

Mannkind Corporation

About

3.25USD+0.29 +9.80%
Closed • Updated at 13:12 GMT+00:00
Market Cap$1.00B
Volume5.18M
Beta2.57
RSI57.64
Gross Margin73.32%
Health TechnologyPharmaceuticals: Major

Mannkind Corporation — investor relations, events, news, and company updates on 6ix.

Latest News

May 6 2026
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
Apr 29 2026
MannKind to Report First Quarter 2026 Financial Results on May 6, 2026
Mar 9 2026
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
Mar 5 2026
MannKind Announces Settlement of Convertible Senior Notes
Mar 4 2026
MannKind to Participate in Upcoming Investor Conferences

Community Chat

Ask AI

6ix6ixAIEvents